Intravenous pamidronate therapy for treatment of osteoporosis. What is the optimum dose?

被引：0
|
作者：
Wimalawansa, SJ [1 ]
机构：
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Div Endocrinol, New Brunswick, NJ 08903 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S173 / S173
页数：1
相关论文
共 50 条
  • [21] Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis
    Gandrud, LM
    Cheung, JC
    Daniels, MW
    Bachrach, LK
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2003, 16 (06): : 887 - 892
  • [22] Intravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosis
    Heijckmann, AC
    Juttmann, JR
    Wolffenbuttel, BHR
    NETHERLANDS JOURNAL OF MEDICINE, 2002, 60 (08): : 315 - 319
  • [23] Effect of intravenous pamidronate for treatment of severe osteoporosis in postmenopausal women
    Povoroznyuk, Vladyslav V.
    Bystrytska, Marina A.
    Orlyk, Tatyana V.
    Dzerovych, Natalija I.
    Vayda, Vladymyr M.
    German, Natalija A.
    BONE, 2008, 42 : S82 - S83
  • [24] Intravenous pamidronate use in osteoporosis. Results of a three year observational study of varying frequency and dosage regimes
    Page, Charlotte E.
    Martin, James C.
    RHEUMATOLOGY, 2008, 47 : II171 - II171
  • [25] Intravenous pamidronate in the management of difficult osteoporosis
    Vasireddy, S.
    Swinson, D. R.
    Harrison, S.
    Selby, P. L.
    RHEUMATOLOGY, 2001, 40 : 96 - 96
  • [26] Intravenous pamidronate in the management of difficult osteoporosis
    Selby, PL
    Vasireddy, S
    Harrison, S
    Swinson, DR
    BONE, 2001, 28 (05) : S226 - S226
  • [27] Pamidronate in osteoporosis treatment
    Sousa, M.
    Simoes, M. E.
    Ribeiro, J. S.
    Cortes, S.
    Figueiredo, R.
    Barcelos, F.
    Santos, H. C.
    Coelho, P.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S263 - S264
  • [28] Intravenous Pamidronate as Treatment for Osteoporosis after Heart Transplantation: A Prospective Study
    M. A. Krieg
    C. Seydoux
    L. Sandini
    J. J. Goy
    D. Gillard Berguer
    D. Thie´baud
    P. Burckhardt
    Osteoporosis International, 2001, 12 : 112 - 116
  • [29] Cyclical intravenous pamidronate in the treatment of severe osteoporosis for upto 6 years
    Bennett, AN
    Smith, GR
    Spector, T
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 447 - 447
  • [30] Intermittent intravenous pamidronate in the treatment of difficult osteoporosis: A review of clinical experience
    Vasireddy, S
    Swinson, DR
    Harrison, S
    Selby, PL
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S63 - S63
12345